MedPath
HSA Approval

DI-ERTRIDE TABLET 25 mg

SIN00108P

DI-ERTRIDE TABLET 25 mg

DI-ERTRIDE TABLET 25 mg

March 16, 1988

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C03AA03

hydrochlorothiazide

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE LTD

Active Ingredients

HYDROCHLOROTHIAZIDE

25 mg

Hydrochlorothiazide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DI-ERTRIDE TABLET 25 mg - HSA Approval | MedPath